2Suppliers
19Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Ardelyx, Inc. (ARDX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships
2Distinct source URLs
8High confidence
0.735Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Ardelyx, Inc. Suppliers

TickerNameConfidenceEvidence
CMOS CMOS 85% Our future results depend on CMOs, many of whom are our single source manufacturers.
GHRS GH Research PLC 62% Reciprocal relationship from GHRS graph: 1 million for the year ended December 31, 2024. This movement is primarily as a result of the translation of our assets and liabilities from their denominated…

Ardelyx, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $36,123 across 6 awards. 36C26025F0017 XPHOZAH; 36C24526N0339 XPHOZAH 30 MG; 36C24526N0202 XPHOZAH 30 MG | Qwen corrected direction: Explicit g…
BIORIDGE-PHARMA-LLC BIORIDGE-PHARMA-LLC 92% Gross product sales from Customers accounting for more than 10% of total revenues were as follows: Three Months Ended March 31, 2026 2025 Customers (1) BioRidge Pharma, LLC 85.5 % 63.8 %
CAREMARK-LLC CAREMARK-LLC 92% Gross product sales from Customers accounting for more than 10% of total revenues were as follows: Three Months Ended March 31, 2026 2025 Customers (1) Caremark, LLC 12.1 % — %
CAH Cardinal Health, Inc. 72% Reciprocal relationship from CAH graph: Reciprocal relationship from ARDX graph: NOTE 4. INVENTORY Inventory consisted of the following: (in thousands) March 31, 2026 December 31, 2025 Raw materials …
CAH Cardinal Health, Inc. 72% NOTE 4. INVENTORY Inventory consisted of the following: (in thousands) March 31, 2026 December 31, 2025 Raw materials $ 27,941 $ 28,009 Work in process 90,043 88,259 Finished goods 10,041 6,839 Total…
MCK McKesson Corporation 72% Reciprocal relationship from MCK graph: Reciprocal relationship from ARDX graph: NOTE 4. INVENTORY Inventory consisted of the following: (in thousands) March 31, 2026 December 31, 2025 Raw materials …
MCK McKesson Corporation 72% NOTE 4. INVENTORY Inventory consisted of the following: (in thousands) March 31, 2026 December 31, 2025 Raw materials $ 27,941 $ 28,009 Work in process 90,043 88,259 Finished goods 10,041 6,839 Total…
SLRC SLR Investment Corp. 72% Reciprocal relationship from SLRC graph: Reciprocal relationship from ARDX graph: Reciprocal relationship from SLRC graph: Reciprocal relationship from ARDX graph: Reciprocal relationship from SLRC g…
SLRC SLR Investment Corp. 72% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
CALIFORNIA-PRIVACY-RIGHTS-ACT-JEFFERIES-JEFFERIE CALIFORNIA-PRIVACY-RIGHTS-ACT-JEFFERIES-JEFFERIE 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
COMMISSION-FOSUN-PHARMA-SHANGHAI-FOSUN-PHARMACEU COMMISSION-FOSUN-PHARMA-SHANGHAI-FOSUN-PHARMACEU 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% rations as a result of these recent events. However, uncertainty may remain over liquidity concerns in the broader financial services industry, and there may be unpredictable impacts to our business …
EXHIBITS-EXHIBIT-INCORPORATED EXHIBITS-EXHIBIT-INCORPORATED 62% rations as a result of these recent events. However, uncertainty may remain over liquidity concerns in the broader financial services industry, and there may be unpredictable impacts to our business …
GOOD-MANUFACTURING-PRACTICE-KNIGHT-KNIGHT-THERAP GOOD-MANUFACTURING-PRACTICE-KNIGHT-KNIGHT-THERAP 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
HONG-KONG-LIMITED HONG-KONG-LIMITED 62% nds, or quality issues, could adversely affect our ability to satisfy demand for our products, which could adversely and materially affect our product sales and operating results, which could signifi…
JEF Jefferies Financial Group Inc. 62% Reciprocal relationship from JEF graph: Reciprocal relationship from ARDX graph: Reciprocal relationship from JEF graph: Reciprocal relationship from ARDX graph: Reciprocal relationship from JEF grap…
KYOWA-KIRIN-KYOWA-KIRIN-CO-LTD KYOWA-KIRIN-KYOWA-KIRIN-CO-LTD 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
LTD-SLR-SLR-INVESTMENT-CORP LTD-SLR-SLR-INVESTMENT-CORP 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…
METIS-METIS-THERAPEUTICS-INC METIS-METIS-THERAPEUTICS-INC 62% ficial intelligence, machine learning and certain automated decision-making technologies HRSA Health Resources and Services Administration AMP average manufacturer price IBS-C irritable bowel syndrom…

Ardelyx, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARDX-DEBT Debt stack $26.5M 90% Market cache reports total debt of $26.5M.
ARDX-DEBT-7835 Warrants outstanding: 2200000 90% xbrl warrant detail from xbrl 2019-12-31.
ARDX-DEBT-7836 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.

Ardelyx, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ardelyx, Inc..

Ardelyx, Inc. Ownership

HolderNameConfidenceEvidence
ARDX-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 238 tracked holders.

Ardelyx, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
STIM Neuronetics, Inc. 100.00 2
ARQT Arcutis Biotherapeutics, Inc. 100.00 2
HLN Haleon plc 100.00 2
MGNX MacroGenics, Inc. 100.00 2
APT Alpha Pro Tech, Ltd. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
GHRS GH Research PLC 100.00 1 ['supplier']
GRDN Guardian Pharmacy Services, Inc. 100.00 2
HRMY Harmony Biosciences Holdings, Inc. 100.00 2
MASI Masimo Corporation 100.00 2
CVS CVS Health Corporation 100.00 2
SCLX Scilex Holding Company 100.00 2
CAH Cardinal Health, Inc. 100.00 1 ['customer']
CLH Clean Harbors, Inc. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
HLNCF Haleon plc 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
HALO Halozyme Therapeutics, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
JEF Jefferies Financial Group Inc. 100.00 1 ['customer']
🔐
ARDX
Unlock ARDX Supply Chain Data
Verified relationships include:
CMOSCMOSSupplier85%
GHRSGH Research PLCSupplier62%
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRSUSGOV-DEPARTMENT-OF-VETER…Customer95%
BIORIDGE-PHARMA-LLCBIORIDGE-PHARMA-LLCCustomer92%
+21 more relationships locked
Subscribe — View plans →